Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment
- PMID: 24986711
- PMCID: PMC4131149
- DOI: 10.1007/s11914-014-0222-3
Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment
Abstract
Skeletal abnormalities are commonly seen in children and adolescents with leukemia. The spectrum ranges from mild pain to debilitating osteonecrosis (ON) and fractures. In this review, we summarize the skeletal manifestations, provide an update on therapeutic strategies for prevention and treatment, and discuss the most recent advances in musculoskeletal research. Early recognition of skeletal abnormalities and strategies to optimize bone health are essential to prevent long-term skeletal sequelae and diminished quality of life observed in children and adolescents with leukemia.
Conflict of interest statement
S. Mostoufi-Moab and J. Halton declare that they have no conflicts of interest.
References
-
- Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics. 2007;119(Suppl 2):S166–S174. - PubMed
-
- Baty JM, Vogt EC. Bone changes of leukemia in children. Am J Roentgenol. 1935;34:310–313.
-
- Simmons CR, Harle TS, Singleton EB. The osseous manifestations of leukemia in children. Radiol Clin N Am. 1968;6(1):115–130. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
